You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Formulation, invitro and invivo evaluation of fast disintegrating tablets of rofecoxib.
- In: SIG Bioavailability/Bioequivalence Posters
- At: New Orleans (USA) (2004)
- Type: Poster
- Poster code: BB-P006
- By: SRIPERUMBUDUR, Pranitha (Kakatiya University, Uni. College of Pharm. Sci., Warangal, India)
- Co-author(s): Patlolla, Ram Reddy (Kakatiya University, WARANGAL, India)
Vobalaboina, Venkateswarlu (Kakatiya University, WARANGAL, India) - Abstract:
Many kinds of rapidly/fast disintegrating tablets have been developed to improve the ease of tablet administration with out any aid of water, especially for elderly and pediatric patients who feel difficulty in swallowing a tablet. Rofecoxib, a selective cyclo-oxygenase (cox-2) inhibitor is approved for the treatment of osteoarthritis, rheumatoid..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026